Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| JUPITER NEUROSCIENCES, INC.JUNS · Entity 8326 | Director | June 02, 2026 | June 05, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
JUPITER NEUROSCIENCES, INC.
Report date June 02, 2026 · Filed June 05, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $0.28 · Expires 2036-06-02 | Direct | 100,000 |
Reported balance
After 2026-06-02 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-06-02 · Grant · Acquired 100,000 · Balance 100,000 F1: The options were granted under the Issuer's 2025 Equity Incentive Plan. The options vest over three years commencing from September 2, 2026 in equal quarterly installments subject to continued service through each vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: The options were granted under the Issuer's 2025 Equity Incentive Plan. The options vest over three years commencing from September 2, 2026 in equal quarterly installments subject to continued service through each vesting date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 02, 2026 Filed Jun 5, 2026 12:23 UTC | JUPITER NEUROSCIENCES, INC. JUNS · Entity 8326 | GrantStock Option · Derivative | 100,000 | $0.00 Strike: $0.28 | $0.00 |
DisclosureSEC source: 0001493152-26-027421 · ownership.xml · derivative · entry 1 Brady Allison W · CIK 0001892261 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2036-06-02 F1 · derivative.exercise_date: The options were granted under the Issuer's 2025 Equity Incentive Plan. The options vest over three years commencing from September 2, 2026 in equal quarterly installments subject to continued service through each vesting date. Read SEC document |
| January 22, 2025 Filed Jan 24, 2025 19:31 UTC | JUPITER NEUROSCIENCES, INC. JUNS · Entity 8326 | Exercise / conversionConvertible Notes · Derivative | 21,750 | $2.80 Strike: $2.80 | $60,900.00 |
DisclosureSEC source: 0001493152-25-003547 · ownership.xml · derivative · entry 2 Brady Allison W · CIK 0001892261 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,750 Underlying: Common Stock · 21,750 shares Expires 2024-12-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of common stock issued upon the conversion of that certain Convertible Promissory Note, dated as of September 9, 2021, with a principal balance of $50,400 and a conversion price of $2.80 per share. Subject to lock-up obligations for 180 days following the closing of the Issuer's initial public offering, as per Lock-Up Agreement, dated as of November 27, 2024, with Dominari Securities LLC. F1 · derivative.underlying_shares: Shares of common stock issued upon the conversion of that certain Convertible Promissory Note, dated as of September 9, 2021, with a principal balance of $50,400 and a conversion price of $2.80 per share. Subject to lock-up obligations for 180 days following the closing of the Issuer's initial public offering, as per Lock-Up Agreement, dated as of November 27, 2024, with Dominari Securities LLC. Read SEC document |
| January 22, 2025 Filed Jan 24, 2025 19:31 UTC | JUPITER NEUROSCIENCES, INC. JUNS · Entity 8326 | Exercise / conversionCommon Stock, par value $0.0001 per share | 21,750 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001493152-25-003547 · ownership.xml · nonDerivative · entry 1 Brady Allison W · CIK 0001892261 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,750 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Shares of common stock issued upon the conversion of that certain Convertible Promissory Note, dated as of September 9, 2021, with a principal balance of $50,400 and a conversion price of $2.80 per share. Subject to lock-up obligations for 180 days following the closing of the Issuer's initial public offering, as per Lock-Up Agreement, dated as of November 27, 2024, with Dominari Securities LLC. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.